Reference SummaryKouri RE, J Natl Cancer Inst 1973 Feb;50(2):363-8

Title

 Relationships between aryl hydrocarbon hydroxylase inducibility and sensitivity to chemically induced subcutaneous sarcomas in various strains of mice.

Authors

 Kouri RE; Salerno RA; Whitmire CE

Journal

 J Natl Cancer Inst

Volume

 50

Issue

 2

Year

 1973

Pages

 363-8

Abstract

Links

 J:25838 – MGI References
4702110 – National Library of Medicine/PubMed

Strain Notes

Strain Note
129P3/J These mice were obtained from the Jackson Laboratory.
B10.BR/J These mice were obtained from the Jackson Laboratory.
C3H/fMai These mice were obtained from Microbiological Associates, Inc., Bethesda, Maryland.
C57BL/10ScSn These mice were obtained from the Jackson Laboratory.
C57BL/6Cum These mice were obtained from Cumberland View Farms, Clinton, Tennessee.
DBA/1J These mice were obtained from the Jackson Laboratory.
DBA/2J These mice were obtained from the Jackson Laboratory.
Snell/Mai These mice were obtained from Microbiological Associates, Inc., Bethesda, Maryland.

Models
Strain Model Name Treatment Agent(s) Organ Affected Frequency Model Details
C3H/fMai Mesodermal cell/mesoblast sarcoma
  • 3-methylcholanthrene (MCA) (3-MC)
 Mesodermal cell/mesoblast

83 - 93
B10.BR/J Mesodermal cell/mesoblast sarcoma
  • 3-methylcholanthrene (MCA) (3-MC)
 Mesodermal cell/mesoblast

52 - 93
C57BL/6Cum Mesodermal cell/mesoblast sarcoma
  • 3-methylcholanthrene (MCA) (3-MC)
 Mesodermal cell/mesoblast

52 - 90
C57BL/10ScSn Mesodermal cell/mesoblast sarcoma
  • 3-methylcholanthrene (MCA) (3-MC)
 Mesodermal cell/mesoblast

40 - 81
129P3/J Mesodermal cell/mesoblast sarcoma
  • 3-methylcholanthrene (MCA) (3-MC)
 Mesodermal cell/mesoblast

47 - 71
Snell/Mai Mesodermal cell/mesoblast sarcoma
  • 3-methylcholanthrene (MCA) (3-MC)
 Mesodermal cell/mesoblast

23 - 81
DBA/2J Mesodermal cell/mesoblast sarcoma
  • 3-methylcholanthrene (MCA) (3-MC)
 Mesodermal cell/mesoblast

42 - 87.5
DBA/1J Mesodermal cell/mesoblast sarcoma
  • 3-methylcholanthrene (MCA) (3-MC)
 Mesodermal cell/mesoblast

15 - 62.5
C3H/fMai Mesodermal cell/mesoblast sarcoma
  • 7,12-dimethylbenz[a]anthracene (DMBA)
 Mesodermal cell/mesoblast

96
B10.BR/J Mesodermal cell/mesoblast sarcoma
  • 7,12-dimethylbenz[a]anthracene (DMBA)
 Mesodermal cell/mesoblast

55
C57BL/6Cum Mesodermal cell/mesoblast sarcoma
  • 7,12-dimethylbenz[a]anthracene (DMBA)
 Mesodermal cell/mesoblast

29
C57BL/10ScSn Mesodermal cell/mesoblast sarcoma
  • 7,12-dimethylbenz[a]anthracene (DMBA)
 Mesodermal cell/mesoblast

42
129P3/J Mesodermal cell/mesoblast sarcoma
  • 7,12-dimethylbenz[a]anthracene (DMBA)
 Mesodermal cell/mesoblast

33
Snell/Mai Mesodermal cell/mesoblast sarcoma
  • 7,12-dimethylbenz[a]anthracene (DMBA)
 Mesodermal cell/mesoblast

35
C3H/fMai Mesodermal cell/mesoblast sarcoma
  • benzo[a]pyrene (BP) (BaP) (B[a]P)
 Mesodermal cell/mesoblast

83
B10.BR/J Mesodermal cell/mesoblast sarcoma
  • benzo[a]pyrene (BP) (BaP) (B[a]P)
 Mesodermal cell/mesoblast

12
C57BL/6Cum Mesodermal cell/mesoblast sarcoma
  • benzo[a]pyrene (BP) (BaP) (B[a]P)
 Mesodermal cell/mesoblast

8.3
C57BL/10ScSn Mesodermal cell/mesoblast sarcoma
  • benzo[a]pyrene (BP) (BaP) (B[a]P)
 Mesodermal cell/mesoblast

14
Snell/Mai Mesodermal cell/mesoblast sarcoma
  • benzo[a]pyrene (BP) (BaP) (B[a]P)
 Mesodermal cell/mesoblast

10